首页> 外国专利> Angiotensin-converting enzyme determn. - based on cleavage of hippuryl peptide substrate

Angiotensin-converting enzyme determn. - based on cleavage of hippuryl peptide substrate

机译:血管紧张素转换酶的测定。 -基于对马尿酰肽底物的切割

摘要

Determn. of angiotensin-converting enzyme (ACE) activity is effected by contacting an ACE-contg. sample with a synthetic substrate selected from hippuryl-glycyl-glycine and hippuryl-histidyl-leucine, and subjecting the mixt. to foline-Wu treatment or dialysis to provide non-pptd. peptide cleavage prods. e.g., glycyl-glycine to histidyl-leucine in soln. The latter may be determined photometrically after arylation with a nitrobenzene deriv., e.g. trinitrobenzenesulphonic acid or 1-fluoro-2,4-dinitrobenzene. Also claimed is the followinq: the therapeutic and diagnostic use of the inhibition of the activity of ACE present in sperm, seminal fluid, prostate tissue, testicular tissue, corneal tissue, macrophages and monocytes, which may lead to, e.g., the induction, inhibition of blocking of the fertilisation process, degeneration or decompsn. of vasoactive substances, or the tracing and chemical characterisation of disease states in the aforementioned tissues (sic). The ACE assay method uses inexpensive reagents and is suitable for use in clinical laboratories. (Fl).
机译:确定。血管紧张素转换酶(ACE)活性的降低是通过接触ACE-contg来实现的。样品具有选自马来酰-甘氨酰-甘氨酸和马来酰-组氨酸-亮氨酸的合成底物,然后混合。给茶疗法或透析提供非pptd。肽裂解产物。例如,在Soln中将甘氨酰-甘氨酸转化为组氨酸-亮氨酸。后者可以在与硝基苯衍生物,例如三氯甲烷芳基化之后,光度法确定。三硝基苯磺酸或1-氟-2,4-二硝基苯。还要求保护以下方面:抑制存在于精子,精液,前列腺组织,睾丸组织,角膜组织,巨噬细胞和单核细胞中的ACE活性的治疗和诊断用途,这可能导致例如诱导,抑制作用。阻止受精过程,变性或分解。血管活性物质的含量,或上述组织的疾病状态的追踪和化学特征(原文如此)。 ACE分析方法使用廉价的试剂,适用于临床实验室。 (Fl)。

著录项

  • 公开/公告号BE896647A

    专利类型

  • 公开/公告日1983-09-01

    原文格式PDF

  • 申请/专利权人 VAN SANDE MARC E.;NEELS HUGO M.;

    申请/专利号BE19830896647

  • 发明设计人

    申请日1983-05-03

  • 分类号G01N;

  • 国家 BE

  • 入库时间 2022-08-22 11:18:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号